Related content

Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells

By                        

Oncology Reports, Vol. 32, Iss. 4, 2014-01 ,pp. : 1401-1408

Spandidos Publications

Access to resources Recommend Favorite

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib

By Maiello Monica   D’Alessio Amelia   Luca Antonella   Carotenuto Adele   Rachiglio Anna   Napolitano Maria   Cito Letizia   Guzzo Antonella   Normanno Nicola  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839)

By Hiscox Stephen   Morgan Liam   Barrow Denise   Dutkowski Carol   Wakeling Alan   Nicholson Robert  

Clinical and Experimental Metastasis, Vol. 21, Iss. 3, 2004-05 ,pp. : 201-212

Springer Publishing Company

Access to resources Recommend Favorite

Longterm exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFRmutant PC9 lung cancer cell line

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 430-436

Spandidos Publications

Access to resources Recommend Favorite

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite